Cargando…
Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells
Chemotherapy is widely used as one of the first line therapeutic methods in cancer patients. However, chemotherapeutic resistance is one of the most common problems in cancer patients, which leads to the therapeutic failure and tumor relapse. Considering the side effects of chemotherapy drugs in nor...
Autores principales: | Maharati, Amirhosein, Samsami, Yalda, Latifi, Hanieh, Tolue Ghasaban, Faezeh, Moghbeli, Meysam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426205/ https://www.ncbi.nlm.nih.gov/pubmed/37580768 http://dx.doi.org/10.1186/s12935-023-03004-7 |
Ejemplares similares
-
MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023) -
MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023) -
Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression
por: Maharati, Amirhosein, et al.
Publicado: (2023) -
Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023) -
PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023)